Louis van Bloois

4.3k total citations
59 papers, 3.5k citations indexed

About

Louis van Bloois is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Louis van Bloois has authored 59 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Immunology. Recurrent topics in Louis van Bloois's work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (12 papers) and Immunotherapy and Immune Responses (10 papers). Louis van Bloois is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (12 papers) and Immunotherapy and Immune Responses (10 papers). Louis van Bloois collaborates with scholars based in Netherlands, Germany and United States. Louis van Bloois's co-authors include Gert Storm, Daan J.A. Crommelin, Raymond M. Schiffelers, G. Storm, Enrico Mastrobattista, Wim J.G. Oyen, Otto C. Boerman, Gerben A. Koning, Frans H.M. Corstens and Twan Lammers and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Louis van Bloois

58 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis van Bloois Netherlands 33 1.6k 908 877 607 424 59 3.5k
Yohei Mukai Japan 32 1.6k 1.0× 807 0.9× 398 0.5× 352 0.6× 381 0.9× 102 3.0k
Teruna J. Siahaan United States 39 2.8k 1.8× 1.1k 1.2× 836 1.0× 634 1.0× 843 2.0× 199 5.8k
Francis J. Martin United States 27 2.0k 1.3× 437 0.5× 1.0k 1.2× 484 0.8× 416 1.0× 42 3.6k
Steven M. Ansell United States 24 3.7k 2.4× 703 0.8× 988 1.1× 559 0.9× 153 0.4× 47 4.9k
Yasuo Yoshioka Japan 35 1.3k 0.8× 666 0.7× 389 0.4× 407 0.7× 499 1.2× 219 4.2k
Rogério Gaspar Portugal 26 1.8k 1.2× 569 0.6× 1.5k 1.7× 973 1.6× 170 0.4× 41 3.8k
Yuting Yang China 36 3.0k 1.9× 693 0.8× 669 0.8× 689 1.1× 298 0.7× 143 5.0k
Ivo Que Netherlands 34 1.5k 1.0× 430 0.5× 306 0.3× 954 1.6× 473 1.1× 85 4.0k
Arcadio Chonn Canada 19 2.2k 1.4× 493 0.5× 1.4k 1.6× 490 0.8× 230 0.5× 23 3.5k
K. Kawano Japan 31 1.4k 0.9× 260 0.3× 1.2k 1.4× 573 0.9× 207 0.5× 110 3.2k

Countries citing papers authored by Louis van Bloois

Since Specialization
Citations

This map shows the geographic impact of Louis van Bloois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis van Bloois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis van Bloois more than expected).

Fields of papers citing papers by Louis van Bloois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis van Bloois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis van Bloois. The network helps show where Louis van Bloois may publish in the future.

Co-authorship network of co-authors of Louis van Bloois

This figure shows the co-authorship network connecting the top 25 collaborators of Louis van Bloois. A scholar is included among the top collaborators of Louis van Bloois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis van Bloois. Louis van Bloois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chong, Suet Yen, Louis van Bloois, Chao Huang, et al.. (2023). Injectable liposomal DHA alleviates atherosclerosis progression and enhances plaque stability. Atherosclerosis. 379. S7–S7.
2.
Kerkhof, Peter van, Louis van Bloois, Ingrid Jordens, et al.. (2023). RSPO3 Furin domain-conjugated liposomes for selective drug delivery to LGR5-high cells. Journal of Controlled Release. 356. 72–83. 6 indexed citations
3.
Tüysüz, Nesrin, Louis van Bloois, Stieneke van den Brink, et al.. (2017). Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells. Nature Communications. 8(1). 14578–14578. 59 indexed citations
4.
Theek, Benjamin, Maike Baues, Tarun Ojha, et al.. (2016). Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. Journal of Controlled Release. 231. 77–85. 142 indexed citations
5.
Pollitt, Christopher C., Josbert M. Metselaar, Peter Laverman, et al.. (2015). Distribution of technetium-99m PEG-liposomes during oligofructose-induced laminitis development in horses. The Veterinary Journal. 206(2). 218–225. 3 indexed citations
6.
Fehres, Cynthia M., Hakan Kalay, Sven C. M. Bruijns, et al.. (2015). Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens. Journal of Controlled Release. 203. 67–76. 56 indexed citations
7.
Bartneck, Matthias, Klaudia Theresa Warzecha, Louis van Bloois, et al.. (2014). Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. Nanomedicine Nanotechnology Biology and Medicine. 10(6). 1209–1220. 79 indexed citations
8.
Deddens, Lisette H., Geralda A. F. van Tilborg, Annette van der Toorn, et al.. (2013). MRI of ICAM-1 Upregulation After Stroke: the Importance of Choosing the Appropriate Target-Specific Particulate Contrast Agent. Molecular Imaging and Biology. 15(4). 411–422. 39 indexed citations
9.
Joshi, Medha, Wendy W. J. Unger, Astrid J. van Beelen, et al.. (2011). DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations. International Journal of Pharmaceutics. 416(2). 426–432. 29 indexed citations
10.
Oerlemans, Chris, J. Frank W. Nijsen, Miranda van Amersfoort, et al.. (2011). A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release. European Journal of Pharmaceutics and Biopharmaceutics. 77(3). 458–464. 7 indexed citations
11.
Smit, Joost J., Ine Hassing, Daniëlle Fiechter, et al.. (2011). Contribution of Classic and Alternative Effector Pathways in Peanut-Induced Anaphylactic Responses. PLoS ONE. 6(12). e28917–e28917. 53 indexed citations
12.
Kunjachan, Sijumon, Andrzej Błauż, Diana Möckel, et al.. (2011). Overcoming cellular multidrug resistance using classical nanomedicine formulations. European Journal of Pharmaceutical Sciences. 45(4). 421–428. 53 indexed citations
13.
Underwood, Charlie J., Andrew W. van Eps, Michael W. Ross, et al.. (2011). Intravenous technetium‐99m labelled PEG‐liposomes in horses: A safety and biodistribution study. Equine Veterinary Journal. 44(2). 196–202. 11 indexed citations
14.
Rozemuller, Henk, et al.. (2004). Enhanced engraftment of human cells in RAG2/γc double-knockout mice after treatment with CL2MDP liposomes. Experimental Hematology. 32(11). 1118–1125. 29 indexed citations
15.
Rijn, Rozemarijn S. van, Elles Simonetti, Anton Hagenbeek, et al.. (2003). A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant mice. Blood. 102(7). 2522–2531. 147 indexed citations
16.
Mastrobattista, Enrico, et al.. (2002). Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins. Journal of Biological Chemistry. 277(30). 27135–27143. 130 indexed citations
17.
Corvo, M. Luísa, Otto C. Boerman, Wim J.G. Oyen, et al.. (1999). Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1419(2). 325–334. 92 indexed citations
18.
Toes, René E. M., Ellen I. H. van der Voort, Stephen P. Schoenberger, et al.. (1998). Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells. The Journal of Immunology. 160(9). 4449–4456. 124 indexed citations
19.
Oyen, Wim J.G., O.C. Boerman, E.T.M. Dams, et al.. (1997). Scintigraphic evaluation of experimental colitis in rabbits.. PubMed. 38(10). 1596–600. 28 indexed citations
20.
Oyen, Wim J.G., Otto C. Boerman, G. Storm, et al.. (1996). Labelled StealthR liposomes in experimental infection. Nuclear Medicine Communications. 17(9). 742–748. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yohei Mukai Breakdown of academic impact, for papers by Teruna J. Siahaan Breakdown of academic impact, for papers by Francis J. Martin Breakdown of academic impact, for papers by Steven M. Ansell Breakdown of academic impact, for papers by Yasuo Yoshioka Breakdown of academic impact, for papers by Rogério Gaspar Breakdown of academic impact, for papers by Yuting Yang Breakdown of academic impact, for papers by Ivo Que Breakdown of academic impact, for papers by Arcadio Chonn Breakdown of academic impact, for papers by K. Kawano
Rankless by CCL
2026